The global vascular stents market, valued at approximately USD 10.57 billion in 2023, is poised for significant growth, with projections indicating a compound annual growth rate (CAGR) of 5.5% between 2024 and 2032. This steady growth is expected to see the market reach an estimated value of USD 17.10 billion by 2032. Vascular stents are medical devices used to support blood vessels that have been narrowed or blocked due to conditions such as atherosclerosis. With technological advancements, an ageing population, and rising rates of cardiovascular diseases, the vascular stents market is undergoing a transformative evolution.
Key Players in the Vascular Stents Market
The vascular stents market is highly competitive, with numerous key players offering innovative products to address the needs of patients suffering from vascular diseases. Some of the key players in this market include:
- Medtronic: A global leader in medical devices, Medtronic offers a wide range of vascular stents that include coronary, peripheral, and renal stents. Their products are well known for their quality and innovative features.
- Abbott Laboratories: Abbott’s stents are widely used in coronary interventions and the treatment of peripheral artery disease. Their innovative drug-eluting stents (DES) have gained popularity due to their ability to reduce the risk of restenosis.
- Boston Scientific: Known for their flagship stent systems like the TAXUS and Synergy stents, Boston Scientific is a major player in the vascular stents market. The company offers drug-coated stents (DCS) that have significantly improved clinical outcomes for patients.
- Johnson & Johnson: Through its subsidiary, Cordis, J&J has become a dominant force in the global vascular stents market. They provide a variety of stent solutions, including drug-eluting and balloon-expandable stents.
- Terumo Corporation: This Japanese company has expanded its global presence in the vascular stents market through the development of cutting-edge, minimally invasive stenting products for both coronary and peripheral applications.
- B. Braun Melsungen: Known for its range of medical devices, B. Braun offers advanced stents that focus on precision and minimal invasiveness, which appeal to both healthcare providers and patients.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/vascular-stents-market/requestsample
Segmentation of the Vascular Stents Market
The vascular stents market can be segmented based on several factors, including type, application, and region. Understanding these segments is crucial for understanding the overall market dynamics.
By Type
- Coronary Stents: These stents are primarily used in the coronary arteries to treat coronary artery disease (CAD), where the arteries are narrowed or blocked by plaque buildup. Drug-eluting stents (DES) and bare-metal stents (BMS) are the two primary categories within coronary stents.
- Peripheral Stents: These stents are designed to treat peripheral artery diseases, including diseases of the arteries outside the heart, such as in the legs and kidneys. Peripheral stents are gaining traction due to the growing incidence of peripheral artery disease (PAD).
- Carotid Stents: Carotid artery stents are used to treat the narrowing of the carotid arteries, which supply blood to the brain. These stents are increasingly being used for patients at risk of stroke.
- Renal Stents: These are used to treat renal artery stenosis, a condition in which the arteries supplying the kidneys become narrow. Renal stents are essential for managing hypertension and kidney failure.
By Material
- Metal Stents: Metal stents, particularly those made from stainless steel, cobalt-chromium, or nickel-titanium (nitinol), have been the traditional choice for vascular interventions.
- Drug-Eluting Stents (DES): These stents are coated with medication that helps prevent restenosis (re-narrowing of the artery). DES have become the preferred choice for coronary artery stenting due to their superior outcomes compared to bare-metal stents.
- Biodegradable Stents: Biodegradable or bioresorbable stents are a relatively new innovation in vascular interventions. These stents dissolve over time, eliminating the long-term complications associated with metal stents.
By End-User
- Hospitals: Hospitals are the largest segment in terms of end-users, owing to the high volume of vascular surgeries and treatments performed in these settings.
- Ambulatory Surgical Centers (ASCs): ASCs are increasingly becoming a popular choice for stent procedures due to their cost-effectiveness and convenience.
- Specialized Clinics: Cardiovascular and nephrology clinics specializing in vascular diseases also contribute significantly to the demand for vascular stents.
Market Outlook and Growth Projections
The vascular stents market is expected to witness strong growth over the next decade, primarily driven by:
- Increasing Cardiovascular Diseases: The global prevalence of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and carotid artery diseases, is increasing due to the ageing population, unhealthy lifestyles, and increasing rates of diabetes and hypertension. This is expected to drive the demand for vascular stents.
- Technological Advancements: The development of drug-eluting stents, biodegradable stents, and stents with advanced coatings will continue to improve patient outcomes and encourage market growth.
- Rising Healthcare Access: Increasing healthcare expenditure and advancements in healthcare infrastructure in emerging economies will contribute to the expansion of the vascular stents market.
- Aging Population: As the global population ages, there will be an increased demand for stents due to the higher incidence of vascular diseases among older individuals.
- Minimally Invasive Procedures: The shift toward minimally invasive procedures and the growing preference for percutaneous coronary interventions (PCI) rather than open surgery are expected to drive the demand for stents.
Key Market Trends
The vascular stents market is seeing several key trends that could influence its growth in the coming years:
- Growing Demand for Drug-Eluting Stents (DES): Drug-eluting stents are widely regarded as the gold standard in vascular intervention, thanks to their ability to significantly reduce the risk of restenosis compared to bare-metal stents.
- Rise of Biodegradable Stents: As patients demand more advanced and sustainable treatment options, the market for biodegradable stents is expected to grow rapidly. These stents dissolve over time, reducing the risk of long-term complications and the need for follow-up surgeries.
- Combination Stent Products: Manufacturers are developing combination stents that integrate multiple therapies into a single device, such as stents combined with drug delivery systems to prevent restenosis and improve long-term clinical outcomes.
- Focus on Targeted Drug Delivery: There is increasing research into stents that provide targeted drug delivery, which helps in better management of cardiovascular conditions and promotes quicker recovery.
- Minimally Invasive Techniques: Advancements in catheter-based technologies have made it easier to insert vascular stents, reducing the risk of complications and improving recovery times.
COVID-19 Impact on the Vascular Stents Market
The COVID-19 pandemic had a significant impact on the vascular stents market. During the peak of the pandemic, elective procedures, including stent placements, were delayed or cancelled to prioritise COVID-19-related care. This led to a temporary reduction in the demand for vascular stents.
However, with the gradual return to normalcy, there has been a rebound in the demand for these devices as healthcare facilities resume elective surgeries. Moreover, the pandemic highlighted the importance of improving healthcare systems, which will drive long-term growth in the cardiovascular medical device industry, including vascular stents.
Vascular Stents Market Size and Share
In 2023, the global vascular stents market was valued at USD 10.57 billion. The market is anticipated to grow at a CAGR of 5.5%, reaching approximately USD 17.10 billion by 2032. North America currently holds the largest market share due to high healthcare spending, advanced medical technologies, and the large number of vascular interventions performed. Europe follows closely, with increasing rates of cardiovascular diseases driving market growth.
The Asia Pacific region is expected to witness the fastest growth, primarily due to improving healthcare infrastructure, a growing population of elderly individuals, and the rising prevalence of lifestyle diseases such as diabetes and hypertension.
Frequently Asked Questions (FAQs)
1. What are vascular stents used for?
Vascular stents are used to treat narrowing or blockage of blood vessels caused by conditions such as coronary artery disease, peripheral artery disease, and carotid artery diseases. They help to keep the blood vessels open and improve blood flow.
2. What are the different types of vascular stents?
Vascular stents can be classified into coronary, peripheral, carotid, and renal stents. They can further be categorized based on materials, such as metal stents, drug-eluting stents, and biodegradable stents.
3. Who are the key players in the vascular stents market?
Key players in the market include Medtronic, Abbott Laboratories, Boston Scientific, Johnson & Johnson, Terumo Corporation, and B. Braun Melsungen.
4. What is the growth rate of the vascular stents market?
The vascular stents market is projected to grow at a CAGR of 5.5% between 2024 and 2032, reaching a value of USD 17.10 billion by 2032.
5. How did COVID-19 affect the vascular stents market?
COVID-19 led to delays in elective surgeries, including vascular stent placements, causing a temporary dip in demand. However, as healthcare services resume, the market is expected to recover and continue growing.
6. What are the key trends in the vascular stents market?
Key trends include the increasing demand for drug-eluting stents, the rise of biodegradable stents, combination therapies, and a focus on minimally invasive techniques.
By understanding these aspects, stakeholders in the vascular stents market can make informed decisions and capitalize on opportunities within this growing sector.
Related Trending Reports
https://www.expertmarketresearch.com/reports/renal-denervation-systems-market
https://www.expertmarketresearch.com/reports/unicompartmental-knee-prostheses-market
https://www.expertmarketresearch.com/reports/botulinum-toxin-market
